Eprinomectin: a derivative of ivermectin suppresses growth and metastatic phenotypes of prostate cancer cells by targeting the β-catenin signaling pathway
Crossref DOI link: https://doi.org/10.1007/s00432-023-04829-5
Published Online: 2023-05-12
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Samy, Angela
Hussein, Mohamed Ali http://orcid.org/0000-0003-0349-7262
Munirathinam, Gnanasekar
Text and Data Mining valid from 2023-05-12
Version of Record valid from 2023-05-12
Article History
Received: 20 March 2023
Accepted: 29 April 2023
First Online: 12 May 2023
Declarations
:
: The authors declare no conflict of interest.
: Not applicable.